On its own, major depressive disorder (MDD) is an incredibly challenging mental health condition for patients across the globe. Unfortunately, MDD does not often exist in isolation; other comorbidities, such
Antidepressant Long Term Risks: A Study
Antidepressants are a central component in the treatment of Major Depressive Disorder (MDD) and other mental health conditions. While they offer significant relief for millions of people globally, concerns regarding
How to help young adults with depression using rTMS: Basic, Translational, and Clinical Research in Neuromodulation
While Depression impacts millions of people across the globe, young adults bear a significant portion of that burden; census data collected in 2021 suggests that around 48% of young adults
Efficacy and Safety of Intranasal Esketamine (Spravato) for Depression: An Update
Research on the efficacy and safety of intranasal esketamine (Spravato) as a treatment for Depression continues. In particular, three recent analyses provide additional background for patients interested in learning more
Akathisia from Antidepressants
Finding the right treatment plan to combat major depressive disorder (MDD) is a complicated and delicate endeavor. While some antidepressants may work to help alleviate the daily burdens of Depression,
Do SSRIS affect fertility? The effect of SSRIs on Semen quality
When it comes to comprehensive treatment plans for mood disorders such as Depression and anxiety, selective serotonin reuptake inhibitors (SSRIs) have long been considered a frontline treatment strategy. While antidepressants
Esketamine (Spravato) Treatment as Part of a Depression Relapse Prevention Plan
Although millions of people are empowered to coexist with their Depression through comprehensive and personalized treatment plans, the long-term management of this condition can often be complicated by the potential
Antidepressant Induced Mania
For decades, antidepressants such as SSRIs have long been regarded as first-line treatment for major depressive disorder (MDD) and other mood disorders; their importance across many different demographics continues to
Pharmacogenetic Testing for Depression: An Update
Selecting effective antidepressants for the treatment Major Depressive Disorder (MDD) is an imprecise practice, with remission rates of just about 30% at the initial treatment choice. The potential of pharmacogenetic
A Study of Single-Dose Psilocybin Treatment for Major Depressive Disorder
Psilocybin Treatment for Major Depressive Disorder (MDD) is a topic of interest for some of the many people struggling with debilitating symptoms of Depression. While not currently approved for the